Evidence map›Paper›PMID 38474469›Full record

ArticleMolecules (Basel, Switzerland)2024

Effect of Diacetylcurcumin Manganese Complex on Rotenone-Induced Oxidative Stress, Mitochondria Dysfunction, and Inflammation in the SH-SY5Y Parkinson's Disease Cell Model.

Ekanong Pirunkaset, Chantana Boonyarat, Juthamart Maneenet, Charinya Khamphukdee, Supawadee Daodee, Orawan Monthakantirat, Suresh Awale, Anake Kijjoa, Yaowared Chulikhit

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Ekanong PirunkasetGraduate School of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.
Chantana BoonyaratDivision of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0003-4065-6090
Juthamart ManeenetDivision of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0002-9926-7092
Charinya KhamphukdeeDivision of Pharmacognosy and Toxicology, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0002-9927-0670
Supawadee DaodeeDivision of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0003-2051-9953
Orawan MonthakantiratDivision of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.
Suresh AwaleNatural Drug Discovery Laboratory, Institute of Natural Medicine, University of Toyama, Toyama 930-0154, Japan.ORCID 0000-0002-5299-193X
Anake KijjoaICBAS-Instituto de Ciências Biomédicas Abel Salazar and CIIMAR, Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-3321-1061
Yaowared ChulikhitDivision of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0001-7317-8721
Khon Kaen University · THUniversidade do Porto · PTUniversity of Toyama · JP

Funding

BCG Economy and Sustainable Development Network through the Center of Excellence Con-sortium under the Reinventing University System/Visiting Professor Program 2023 KKUNational Science, Research, and Innovation Fund (Fundamental Fund of Khon Kaen University) 65A103000143Scholarships for the master's degree student, Faculty of Pharmaceutical Sciences, Khon Kaen University ID:3-(1)/2563Scholarships for the master's degree student, Faculty of Pharmaceutical Sciences, Khon Kaen University ID-65-1(1)/65
6 · The paper itself

Abstract

Diacetylcurcumin manganese complex (DiAc-Cp-Mn) is a diacetylcurcumin (DiAc-Cp) derivative synthesized with Mn (II) to mimic superoxide dismutase (SOD). It exhibited superior reactive oxygen species (ROS) scavenging efficacy, particularly for the superoxide radical. The present study investigated the ROS scavenging activity, neuroprotective effects, and underlying mechanism of action of DiAc-Cp-Mn in a cellular model of Parkinson's disease. This study utilized rotenone-induced neurotoxicity in SH-SY5Y cells to assess the activities of DiAc-Cp-Mn by measuring cell viability, intracellular ROS, mitochondrial membrane potential (MMP), SOD, and catalase (CAT) activities. The mRNA expression of the nuclear factor erythroid 2 p45-related factor (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), inducible nitric oxide synthase (iNOS), and Interleukin 1β (IL-1β), which are oxidative and inflammatory genes, were also evaluated to clarify the molecular mechanism. The results of the in vitro assays showed that DiAc-Cp-Mn exhibited greater scavenging activity against superoxide radicals, hydrogen peroxide, and hydroxyl radicals compared to DiAc-Cp. In cell-based assays, DiAc-Cp-Mn demonstrated greater neuroprotective effects against rotenone-induced neurotoxicity when compared to its parent compound, DiAc-Cp. DiAc-Cp-Mn maintained MMP levels, reduced intracellular ROS levels, and increased the activities of SOD and CAT by activating the Nrf2-Keap1 signaling pathway. In addition, DiAc-Cp-Mn exerted its anti-inflammatory impact by down-regulating the mRNA expression of iNOS and IL-1β that provoked neuro-inflammation. The current study indicates that DiAc-Cp-Mn protects against rotenone-induced neuronal damage by reducing oxidative stress and inflammation.

Indexed as

Mitochondrial DiseasesNeuroblastomaNeuroprotective AgentsNeurotoxicity SyndromesParkinson DiseaseAntioxidantsCurcuminHumansInflammationKelch-Like ECH-Associated Protein 1ManganeseNF-E2-Related Factor 2Oxidative StressReactive Oxygen SpeciesRNA, MessengerRotenoneAntioxidantsCurcumindiacetylcurcuminKelch-Like ECH-Associated Protein 1ManganeseNeuroprotective AgentsNF-E2-Related Factor 2Reactive Oxygen SpeciesRNA, MessengerRotenoneSuperoxide Dismutasediacetylcurcumin manganese complexNrf2 regulationoxidative stressParkinson’s diseaseSOD mimics

Identifiers

PMID38474469
PMCPMC10934569
OpenAlexW4392102610

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.